全球慢性呼吸道疾病科学小组：背景文件

Background paper Global scientific panel on chronicrespiratory diseases Background paper Global scientific panel on chronic respiratory diseases: background paper ISBN978-92-4-011593-4(electronic version)ISBN 978-92-4-011594-1 (print version) © World Health Organization2025 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0IGO licence (CCBY-NC-SA3.0IGO;https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercialpurposes, providedthe work is appropriately cited, as indicated below. In any use of this work, thereshould be no suggestion that WHO endorses any specific organization, products or services. The useof the WHO logo is not permitted. If you adapt the work, then you must license your work under thesame or equivalent Creative Commons licence. If you create a translation of this work, you shouldadd the following disclaimer along with the suggested citation:“This translation was not created bythe World Health Organization (WHO). WHO is not responsible for the content or accuracy of thistranslation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance withthe mediation rules of the World Intellectual Property Organization(http://www.wipo.int/amc/en/mediation/rules/). Suggested citation.Global scientific panel on chronic respiratory diseases: background paper.Geneva: World Health Organization;2025. Licence:CCBY-NC-SA3.0IGO. Cataloguing-in-Publication (CIP) data.CIP data are available athttps://iris.who.int/. Sales, rights and licensing.To purchase WHO publications, seehttps://www.who.int/publications/book-orders. To submit requests for commercial use and querieson rights and licensing, seehttps://www.who.int/copyright. Third-party materials.If you wish to reuse material from this work that is attributed to a third party,such as tables, figures or images, it is your responsibility to determine whether permission is neededfor that reuse and to obtain permission from the copyright holder. Therisk of claims resulting frominfringement of any third-party-owned component in the work rests solely with the user. General disclaimers.The designations employed and the presentation of the material in thispublication do not imply the expression of any opinion whatsoever on the part of WHO concerningthe legal status of any country, territory, city or area or of its authorities, or concerning thedelimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximateborder lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that theyare endorsed or recommended by WHOin preference to others of a similar nature that are notmentioned. Errors and omissions excepted, the names of proprietary products are distinguished byinitial capital letters. All reasonable precautions have been taken by WHOto verify the information contained in thispublication. However, the published material is being distributed without warranty of any kind,either expressed or implied. The responsibility for the interpretation and use of the material lies withthe reader.In no event shall WHObe liable for damages arising from its use. Contents Acknowledgements................................................................................................................................ivAbbreviations.........................................................................................................................................viContext....................................................................................................................................................11. Take action to address chronic respiratory diseases (CRDs)..............................................................21.1 CRDs are relatively neglected in the global health and research agenda....................................21.2 Member States have a strong mandate to address CRDs, as part of the NCD agenda................21.3 People living with asthma and COPD in less-resourced settings are disproportionately affected............................................................................................................................................................31.4 NCDs, including CRDs, must be part of strengthened primary health care and universal healthcoverage..............................................................................................................................................41.5 Vulnerable populations are particularly affected by CRDs, with increased exposure to riskfactors and inadequate access to diagnosis and treatment...............................................................42. Foster multisectoral partnerships..............